The ASX kissed a record high on Tuesday, led by tech, energy and gold stocks, with gold rising above US$2600. ... Read More ...

Health care and tech innovation go hand in hand. From delivering steady streams of medication to speeding up treatment of ...

Ms. Turner brings to LB Pharma over two decades of executive leadership experience in the biotechnology industry, with a proven track record of driving growth and executing high-value transactions.

Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain rights in Japan to an experimental heart drug, as the German group strengthens its cardiovascular ...

Napo Pharmaceuticals has established a sustainable harvesting program, under fair trade practices, for crofelemer to ensure a high degree of quality, ecological integrity, and support for indigenous ...

Healthcare executives and investors expect an uptick in initial public offerings and corporate dealmaking in 2025, with geopolitical tensions overtaking funding challenges as the biggest risk to the ...

German drugs-to-crops giant Bayer will have an exclusive license to develop and commercialize aficamten in Japan. Cytokinetics has filed for U.S. Food & Drug Administration approval of aficamten in ...

The disengagement along the borders has provided the opportunity to “look into the future”, Chinese officials and top ...